145 related articles for article (PubMed ID: 38126028)
21. Human lung cancer-associated fibroblasts enhance motility of non-small cell lung cancer cells in co-culture.
Kim SH; Choe C; Shin YS; Jeon MJ; Choi SJ; Lee J; Bae GY; Cha HJ; Kim J
Anticancer Res; 2013 May; 33(5):2001-9. PubMed ID: 23645749
[TBL] [Abstract][Full Text] [Related]
22. Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index.
Wu R; Ma R; Duan X; Zhang J; Li K; Yu L; Zhang M; Liu P; Wang C
Front Immunol; 2023; 14():1236444. PubMed ID: 37841237
[TBL] [Abstract][Full Text] [Related]
23. Integrating single-cell and bulk RNA sequencing to develop a cancer-associated fibroblast-related signature for immune infiltration prediction and prognosis in lung adenocarcinoma.
Huang X; Xiao H; Shi Y; Ben S
J Thorac Dis; 2023 Mar; 15(3):1406-1425. PubMed ID: 37065583
[TBL] [Abstract][Full Text] [Related]
24. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
25. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
26. Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC.
Della Corte CM; Ciaramella V; Ramkumar K; Vicidomini G; Fiorelli A; Nardone V; Cappabianca S; Cozzolino I; Zito Marino F; Di Guida G; Wang Q; Cardnell R; Gay CM; Ciardiello D; Martinelli E; Troiani T; Martini G; Napolitano S; Wang J; Byers LA; Ciardiello F; Morgillo F
J Transl Med; 2022 Nov; 20(1):541. PubMed ID: 36419183
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia increases membrane metallo-endopeptidase expression in a novel lung cancer ex vivo model - role of tumor stroma cells.
Leithner K; Wohlkoenig C; Stacher E; Lindenmann J; Hofmann NA; Gallé B; Guelly C; Quehenberger F; Stiegler P; Smolle-Jüttner FM; Philipsen S; Popper HH; Hrzenjak A; Olschewski A; Olschewski H
BMC Cancer; 2014 Jan; 14():40. PubMed ID: 24460801
[TBL] [Abstract][Full Text] [Related]
28. Transcription factor RUNX3 promotes CD8
Song Q; Shang J; Zhang C; Chen J; Zhang L; Wu X
J Cell Biochem; 2020 Jun; 121(5-6):3208-3220. PubMed ID: 31898342
[TBL] [Abstract][Full Text] [Related]
29. Prognostic and Immunological Role of FAT Family Genes in Non-Small Cell Lung Cancer.
Feng Z; Yin Y; Liu B; Zheng Y; Shi D; Zhang H; Qin J
Cancer Control; 2022; 29():10732748221076682. PubMed ID: 35212236
[TBL] [Abstract][Full Text] [Related]
30. CXCR1 correlates to poor outcomes of EGFR-TKI against advanced non-small cell lung cancer by activating chemokine and JAK/STAT pathway.
Yang F; Zhang S; Meng Q; Zhou F; Pan B; Liu F; Yu Y
Pulm Pharmacol Ther; 2021 Apr; 67():102001. PubMed ID: 33582208
[TBL] [Abstract][Full Text] [Related]
31. [CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer].
Tan Q; Li H; Yu M; Tang X; Tan J; Zhang S; Wang J
Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):254-264. PubMed ID: 33910273
[TBL] [Abstract][Full Text] [Related]
32. High Expression of
Chen Y; Zhou M; Gu X; Wang L; Wang C
Dis Markers; 2022; 2022():8789515. PubMed ID: 35855850
[TBL] [Abstract][Full Text] [Related]
33.
Zhang W; Bouchard G; Yu A; Shafiq M; Jamali M; Shrager JB; Ayers K; Bakr S; Gentles AJ; Diehn M; Quon A; West RB; Nair V; van de Rijn M; Napel S; Plevritis SK
Cancer Res; 2018 Jul; 78(13):3445-3457. PubMed ID: 29760045
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
Wang W; Ren S; Wang Z; Zhang C; Huang J
Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
[TBL] [Abstract][Full Text] [Related]
35. Correlation between metastasis-associated gene 1 expression and tumor-associated macrophages in non-small cell lung cancer.
Ma K; Li YX; Guo QQ
Neoplasma; 2022 Sep; 69(5):1092-1100. PubMed ID: 35951452
[TBL] [Abstract][Full Text] [Related]
36. [Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
Zhu G; Li Y; Shi R; Xu S; Zhang Z; Cao P; Chen C; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):236-244. PubMed ID: 33910272
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.
Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L
Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150
[TBL] [Abstract][Full Text] [Related]
38. Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma.
Theelen WSME; Krijgsman O; Monkhorst K; Kuilman T; Peters DDGC; Cornelissen S; Ligtenberg MA; Willems SM; Blaauwgeers JLG; van Noesel CJM; Peeper DS; van den Heuvel MM; Schulze K
J Transl Med; 2020 Jul; 18(1):271. PubMed ID: 32620126
[TBL] [Abstract][Full Text] [Related]
39. Aberrant Expression of β-Catenin Correlates with Infiltrating Immune Cells and Prognosis in NSCLC.
Zheng H; Ning Y; Yang Y; Zhan Y; Wang H; Wen Q; Peng J; Fan S
Pathol Oncol Res; 2021; 27():1609981. PubMed ID: 34764821
[No Abstract] [Full Text] [Related]
40. Intratumoral immunoglobulin isotypes predict survival in lung adenocarcinoma subtypes.
Isaeva OI; Sharonov GV; Serebrovskaya EO; Turchaninova MA; Zaretsky AR; Shugay M; Chudakov DM
J Immunother Cancer; 2019 Oct; 7(1):279. PubMed ID: 31665076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
